Notably, over 65% of patients exhibited positive PSMA PET/CT results, which correlated with Gleason scores and PSA levels, thereby demonstrating the utility of PSMA PET/CT in predicting BR in PC patients [61]. The gene discussed is FOLH1; the disease is pachyonychia congenita.